findmyKOL
Clinical trialNCT02634320CompletedPhase 4Interventional

A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia

SponsorAlkermes, Inc.Enrollment51Schizophrenia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alkermes Investigational Site

    Little Rock, Arkansas, United States

  • Alkermes Investigational Site

    Rogers, Arkansas, United States

  • Alkermes Investigational Site

    Anaheim, California, United States

  • Alkermes Investigational Site

    Culver City, California, United States

  • Alkermes Investigational Site

    Garden Grove, California, United States

  • Alkermes Investigational Site

    National City, California, United States

  • Alkermes Investigational Site

    Oceanside, California, United States

  • Alkermes Investigational Site

    Orange, California, United States

  • Alkermes Investigational Site

    Panorama City, California, United States

  • Alkermes Investigational Site

    Augusta, Georgia, United States

  • Alkermes Investigational Site

    Chicago, Illinois, United States

  • Alkermes Investigational Site

    Shreveport, Louisiana, United States

  • Alkermes Investigational Site

    St Louis, Missouri, United States

  • Alkermes Investigational Site

    Garfield Heights, Ohio, United States

  • Alkermes Investigational Site

    Lincoln, Rhode Island, United States

  • Alkermes Investigational Site

    Dallas, Texas, United States

  • Alkermes Investigational Site

    Dallas, Texas, United States

  • Alkermes Investigational Site

    DeSoto, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2015
Primary completion
11 Jul 2017
Completion
11 Jul 2017
Last update posted
4 Dec 2018
Registered enrollment
51
Registry id
NCT02634320

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.